This paper analyzes the accessibility, quantity, and time frame of forward-looking information disclosed by the 25 constituents in the S&P 500 Pharmaceuticals, Biotechnology & Life Sciences GICS industry classifications.

Former Chairman and CEO of Best Buy Hubert Joly provided his perspective on leadership and success(ion) planning. Ahead of his new book, The Heart of Business: Leadership Principles for the Next Era of Capitalism, Joly discussed what he calls “human magic” and how to mobilize people to give their best as business, with people at the … Continue reading

This event builds upon collaborative work that started when the Covid-19 pandemic hit in the spring of 2020. During that time, ACCP, CECP, Council on Foundations, and Points of Light came together to support leaders of corporate purpose in acting with courage and determination to respond to the compounding health and economic crises. The executive … Continue reading

Carmine Di Sibio, CEO, EY led a discussion on CEO priorities as we emerge from the Covid-19 pandemic, bringing in recent EY research from the CEO Imperative Series.  This session focused on what “building back better” looks like, the difficulties and opportunities of a stakeholder-focused strategy, and efforts to shift ESG reporting from chasing compliance to projecting long-term … Continue reading

Investing in Society (IIS) is the authoritative source to assess the corporate sector’s progress toward being increasingly purpose and stakeholder driven. CECP’s assessment combines rigorous analysis with research, trends, and cases from the ESG landscape, examined through the lens of CECP’s engagements with more than 200 of the world’s leading companies.

Developed from CECP’s premier research on, thought leadership for, and strategic engagements with more than 200 of the world’s largest companies, this digital release brings to light the state of corporate purpose in an evidence-based way and assesses corporate purpose-driven actions under the categories of Priorities, Performance, People, Planet, and Policies.

A comprehensive look back at the biggest trends and insights that defined the Corporate Social Engagement space in 2018.

Developed from CECP’s premier research on, thought leadership for, and strategic engagements with more than 200 of the world’s largest companies, this digital release brings to light the state of corporate purpose in an evidence-based way and assesses corporate purpose-driven actions.

Co-authored by CECP’s CEO Investor Forum and the Biopharma Sustainability Roundtable, the Integrating Sustainability Report provides sector-specific tools for biopharma CEOs and their teams as they prepare their sustainable Long-Term Plans for investors.

Vanguard Chair Bill McNabb and NRG President & CEO Mauricio Gutierrez shared their insights on the power of sharing Long Term Plans, from the corporate issuer and investor perspectives. The conversation focused on how investor expectations are changing as demand for longer-term, forward-looking disclosures continue to grow, including integrating material ESG issues and metrics.